Biomarkers of cardiovascular disease: molecular basis and practical considerations
RS Vasan - Circulation, 2006 - Am Heart Assoc
echocardiogram) may be expected to facilitate the identification of patients with chest pain of
an ischemic etiology (angina). In a patient presenting to the emergency department with …
an ischemic etiology (angina). In a patient presenting to the emergency department with …
Genetic susceptibility to coronary artery disease: from promise to progress
H Watkins, M Farrall - Nature Reviews Genetics, 2006 - nature.com
Family history is an important independent risk factor for coronary artery disease (CAD), and
identification of susceptibility genes for this common, complex disease is a vital goal …
identification of susceptibility genes for this common, complex disease is a vital goal …
Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility
X Wang, M Ria, PM Kelmenson, P Eriksson… - Nature …, 2005 - nature.com
Ath1 is a quantitative trait locus on mouse chromosome 1 that renders C57BL/6 mice
susceptible and C3H/He mice resistant to diet-induced atherosclerosis. The quantitative trait …
susceptible and C3H/He mice resistant to diet-induced atherosclerosis. The quantitative trait …
Association of the HLA–DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis
TM Farragher, NJ Goodson, H Naseem… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To examine the role of the variants of the PTPN22 and HLA–DRB1 genes as
predictors of mortality in inflammatory polyarthritis (IP) and rheumatoid arthritis (RA) …
predictors of mortality in inflammatory polyarthritis (IP) and rheumatoid arthritis (RA) …
Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on …
DK Arnett, AE Baird, RA Barkley, CT Basson… - Circulation, 2007 - Am Heart Assoc
Atherosclerotic cardiovascular disease (CVD) is a major health problem in the United States
and around the world. Evidence accumulated over decades convincingly demonstrates that …
and around the world. Evidence accumulated over decades convincingly demonstrates that …
Molecular genetics of coronary artery disease
Q Wang - Current opinion in cardiology, 2005 - journals.lww.com
Genetic studies provide new insights into the pathogenesis of coronary artery disease and
myocardial infarction. Future studies will focus on identification of new disease-causing …
myocardial infarction. Future studies will focus on identification of new disease-causing …
Genetic contributors toward increased risk for ischemic heart disease
Cardiovascular disease is a leading cause of mortality in the United States, and is a
significant cause of death worldwide. In 2002, it accounted for 38.0% of all deaths in the US …
significant cause of death worldwide. In 2002, it accounted for 38.0% of all deaths in the US …
Pharmacogenetics in drug discovery and development: a translational perspective
AD Roses - Nature reviews Drug discovery, 2008 - nature.com
The ability to predict a patient's drug response on the basis of their genetic information is
expected to decrease attrition during the development of new, innovative drugs, and reduce …
expected to decrease attrition during the development of new, innovative drugs, and reduce …
Genetic susceptibility to myocardial infarction and coronary artery disease
Atherosclerotic involvement in the coronary arteries, which can result in heart attack and
sudden death, is a common disease and prototypic of a complex human trait. To understand …
sudden death, is a common disease and prototypic of a complex human trait. To understand …
[HTML][HTML] Lack of MEF2A mutations in coronary artery disease
L Weng, N Kavaslar, A Ustaszewska… - The Journal of …, 2005 - Am Soc Clin Investig
Mutations in MEF2A have been implicated in an autosomal dominant form of coronary artery
disease (adCAD1). In this study we sought to determine whether severe mutations in MEF2A …
disease (adCAD1). In this study we sought to determine whether severe mutations in MEF2A …